… Assorted lineages of stem cells are considered a good treatment for SCI. This study … stem
cells (MSCs) in a compressive SCI model. Here we present results of the intraperitoneal route, …

It is unclear how systemic administration of mesenchymal stem cells (MSCs) controls local
inflammation. The aim of this study was to evaluate the therapeutic effects of human MSCs on …

… Therefore, we report a comparison between intravenous and intraperitoneal routes of cell
transplantation. Clarifying the best methodology for cell therapy may enhance the success of …

… The cells have usually been injected intravenously, but beneficial effects have also been
reported with intraperitoneal (IP) injection of MSC. However the fate of IP injection of MSC has …

… to try the intraperitoneal administration of human umbilical cord blood cells in toxic hepatitis
in immunocompetent rats. We designed this protocol based on HSC infusion following liver …

… To our knowledge, this is the first study in which a comparison of intraperitoneal and
intravenous routes of adipose tissue mesenchymal stem cell (AT-MSCs) delivery on EAE …

… Our results indicated that the intraperitoneal injection is the best delivery way for MSCs,
which showed better mucosa recovery and higher cell engraftment at inflamed colon. These …

… immune effects to local cell replacement, have been proposed. Here we used intraperitoneal
delivery of human mesenchymal stem cells to help test (a) whether human cells can indeed …

… in clinical practice, the intraperitoneal (ip) route has been rarely used for cell delivery (12). …
the possible effect of intraperitoneal human cord blood mesenchymal stem cell therapy on …

… g/kg body weight prior to the infusion of cell suspension. In order to test the effectiveness and
… For intraperitoneal cavity infusion, 1 ml of labeled cell suspension was directly injected into …